Archived Insight | May 5, 2021

Digital Transformation in Healthcare

The coupling of virtual technologies with remote medicine disrupts the idea that having a regular relationship with a local primary care provider which is necessary to manage chronic illness and overall health and well-being.

Younger generations prefer interacting with the health system in the same way they purchase other goods and services, virtually and on-demand. Expectations are high for on-demand access to information on costs, quality and satisfaction.

digital transformation in healthcare

Here's what you will learn

In this 60 minute webinar held on May 5, you’ll:

  • Learn which clinical categories are most appropriate for a digital solution
  • Gain insight into some of the prominent companies that are emerging in this field
  • Learn to identify the best digital therapeutics to match the needs of the population
  • Learn how these programs can potentially reduce medical claims and create a healthier workforce

 

Watch the Webinar

 

 

Get the slides from this webinar

Don’t have time to watch a video right now? No worries. Here is a copy of the slides.

Download the Slides

Read more insights

Young Couple Going Over Financial Documents At Home

Final Rule on Healthcare Transparency in Coverage

Learn how the Transparency in Coverage final rule affects disclosure requirements, price comparison tools and implementation planning.

Health, Compliance, Healthcare Industry, Higher Education, Multiemployer Plans, Public Sector, Corporate

Read Full Insight

Asian Female Pharmacist Uses Computer To Check Inventory For A Drug

Designing and Negotiating Affordable Pharmacy Benefits

Learn how health plan sponsors can improve pharmacy benefit value through PBM contracting, formulary management and clinical oversight.

Health, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Corporate, Pharmaceutical, Healthcare Cost Management

Read Full Insight

Man Self Injecting GLP 1 Weight Loss Medication Pen At Home

GLP-1s Have Disrupted the Market for Other Diabetes Drugs

Segal’s SHAPE data shows how rising GLP-1 use coincided with declines in insulin, Metformin and DPP-4 inhibitor use.

Health, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Corporate, Pharmaceutical

Read Full Insight

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.